COVID-19 contagion concern scale (PRE-COVID-19): Validation in Cuban patients with type 2 diabetes

• Autores: Caycho-Rodríguez, Tomás, Vilca, Lindsey W., Corrales-Reyes, Ibraín Enrique, Hernández-García, Frank, Pupo Pérez, Antonio, González Quintana, Patricia, Pérez García, Enrique Rolando, Lazo Herrera, Luis Alberto, White, Michael
• Formato: artículo
• Fecha de Publicación: 2021
• Institución: Universidad Privada del Norte
• Repositorio: UPN-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.upn.edu.pe:11537/28457
• Enlace del recurso: https://hdl.handle.net/11537/28457; https://doi.org/10.1016/j.dsx.2021.102245
• Nivel de acceso: acceso abierto
• Materia: Miedo; Pacientes; Diabetes mellitus; Covid-19; https://purl.org/pe-repo/ocde/ford#5.01.02

ABSTRACT Aims It is important to have valid and reliable measures to determine the psychological impact of COVID-19 in patients with diabetes; however, few instruments have been developed and validated for this population. Therefore, the aim of this study was to validate the Scale of Worry for Contagion of COVID-19 (PRE-COVID-19) in a sample of patients with diabetes mellitus (DM). Materials and methods A total of 219 patients (66.2% female, mean age 58.5 SD = 18.2) participated, selected through non-probabilistic sampling. The PRE-COVID-19 and the Generalized Anxiety Disorder Scale-2 were applied. Reliability analysis was performed for internal consistency, structural equation modeling and item response theory modeling. Results The results show that a unidimensional 5-item model presents satisfactory goodness-of-fit indices and excellent reliability values. Likewise, convergent validity between the PRE-COVID-19 and a measure of anxiety is evident. All items present adequate discrimination parameters, allowing for discerning between those patients with critical concern about COVID-19 contagion from those with severe concern. Conclusion It is concluded that the PRE-COVID-19 is an instrument with adequate psychometric properties to measure concern about COVID-19 infection and the emotional impact in patients with DM.